A disease-modifying approach to the treatment of IgA nephropathy targeting mucosal IgA synthesis and beyond

被引：5
|
作者：
Coppo, Rosanna [1 ,2 ]
机构：
[1] Regina Margher Hosp, Fdn Riverca Molinette, Turin, Italy
[2] Fdn Ric Molinette, Via Valeggio 41, I-10129 Turin, Italy
来源：
KIDNEY INTERNATIONAL | 2023年 / 103卷 / 02期
关键词：
D O I：
10.1016/j.kint.2022.10.019
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The benefits and risks of systemic corticosteroids in the treatment of IgA nephropathy are still controversial. Part A results of the Efficacy and Safety of Nefecon in Patients With Primary IgA Nephropathy (NefIgArd) trial provide significant effects on decrease in proteinuria and protection from estimated glomerular filtration rate decline after 9 months of treatment with budesonide (Nefecon). Targeting the initiating pathogenetic event in the gut-associated lymphoid tissue would offer a and possible multiple effects of this treatment are critically discussed.
引用
收藏
页码：258 / 261
页数：4
相关论文
共 50 条
  • [1] A Disease-Modifying Role for Mucosal IgA Antibodies to Citrullinated Antigens?
    Svard, Anna
    Kastbom, Alf
    Sommarin, Yngve
    Skogh, Thomas
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S849 - S849
  • [2] A DISEASE-MODIFYING ROLE FOR MUCOSAL IGA ANTIBODIES TO CITRULLINATED ANTIGENS?
    Svard, Anna
    Kastbom, Alf
    Sommarin, Yngve
    Skogh, Thomas
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71
  • [3] Targeting APRIL in the Treatment of IgA Nephropathy
    Cheung, Chee Kay
    Barratt, Jonathan
    Carroll, Kevin
    Lafayette, Richard A.
    Liew, Adrian
    Suzuki, Yusuke
    Tesar, Vladimir
    Trimarchi, Hernan
    Wong, Muh Geot
    Zhang, Hong
    Perkovic, Vlado
    Rizk, Dana V.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (03): : 394 - 398
  • [4] Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue
    Barratt, Jonathan
    NEPHROLOGY, 2024, 29 : 34 - 36
  • [5] The mucosal microbiome and IgA nephropathy: a new target for treatment?
    Selvaskandan, Haresh
    Barratt, Jonathan
    KIDNEY INTERNATIONAL, 2024, 106 (06) : 1008 - 1011
  • [6] Further Evidence for the Mucosal Origin of Pathogenic IgA in IgA Nephropathy
    Cheung, Chee Kay
    Barratt, Jonathan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (05): : 873 - 875
  • [7] IgA nephropathy: is a new approach beyond proteinuria necessary?
    Eduardo Gutiérrez
    Pediatric Nephrology, 2019, 34 : 921 - 924
  • [8] IgA nephropathy: is a new approach beyond proteinuria necessary?
    Gutierrez, Eduardo
    PEDIATRIC NEPHROLOGY, 2019, 34 (05) : 921 - 924
  • [9] Targeting complement in IgA nephropathy
    Caravaca-Fontan, Fernando
    Gutierrez, Eduardo
    Sevillano, angel M.
    Praga, Manuel
    CLINICAL KIDNEY JOURNAL, 2023, 16 : ii28 - ii39
  • [10] FOOD, MUCOSAL IMMUNITY, AND IGA NEPHROPATHY
    KOLACEK, S
    BOOTH, IW
    TAYLOR, CM
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1990, 11 (02): : 175 - 178
12345